Agilent Technologies Inc(A) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 28.18 | EPS (ttm) | 5.08 | Insider Own | 0.34% | Shs Outstand | 282.0M | Perf Week | -5.46% |
| Market Cap | 40.35B | Forward P/E | 21.22 | EPS next Y | 8.75% | Insider Trans | -0.23% | Shs Float | 281.0M | Perf Month | -4.26% |
| Enterprise Value | 42.54B | PEG | 2.09 | EPS next Q | 1.73 | Inst Own | 95.53% | Short Float | 1.84% | Perf Quarter | 8.74% |
| Income | 1.44B | P/S | 5.47 | EPS this Y | 10.95% | Inst Trans | 1.15% | Short Ratio | 2.35 | Perf Half Y | 24% |
| Sales | 7.37B | P/B | 5.48 | EPS next 5Y | 10.16% | ROA | 11% | Short Interest | 5.17M | Perf YTD | 5.18% |
| Book/sh | 26.11 | P/C | 22.95 | EPS past 3/5Y | 3.03% 14.68% | ROE | 20.97% | 52W High | -12.6% ($163.75) | Perf Year | 15.31% |
| Cash/sh | 6.24 | P/FCF | 31.85 | Sales past 3/5Y | 0.48% 5.41% | ROIC | 13.08% | 52W Low | 32.09% ($108.35) | Perf 3Y | 25.55% |
| Dividend Est. | $1.02 (0.71%) | EV/EBITDA | 20.78 | EPS Y/Y TTM | 19.07% | Gross Margin | 53.72% | Volatility(W/M) | 2.91% 2.7% | Perf 5Y | -19.25% |
| Dividend TTM | 1.01 | EV/Sales | 5.77 | Sales Y/Y TTM | 8.6% | Oper. Margin | 24.09% | ATR (14) | 4.37 | Perf 10Y | 218.89% |
| Dividend Ex-Date | 2026/6/30 | Quick Ratio | 1.56 | EPS Q/Q | 8.5% | Profit Margin | 19.53% | RSI (14) | 40.64 | Recom | 1.81 |
| Dividend Gr. 3/5Y | 5.63% 6.58% | Current Ratio | 2.05 | Sales Q/Q | 8.06% | SMA20 | -5.55% ($151.53) | Beta | 1.23 | Target Price | $175.58 |
| Payout | 21.7% | Debt/Eq | 0.54 | Earnings | 2026/8/26 | SMA50 | 0.09% ($142.99) | Rel Volume | 0.69 | Prev Close | $144.75 |
| Employees | 18100 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | 8.85% 1.98% | SMA200 | 8.76% ($131.59) | Avg Volume(3M) | 2.20M | Price | $143.12 |
| IPO | 1999/11/18 | Option/Short | Yes/Yes | Trades | 22010 | Volume | 1,520,254 | Change | -1.13% |
Company
A is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 A specialty analytical instruments company that supplies global life science, diagnostics, and applied analysis equipment, reagents, and software solutions. Spun off from its former parent company in 1999 and headquartered in Santa Clara, California, it is a key pillar of a global analytical instruments group that provides a wide range of analytical instruments, consumable reagents, and services to the pharmaceutical, biotechnology, food, environmental, and clinical diagnostics fields.
Over the past 1 year, roughly in the middle
13% below its 1-year high.
A makes money exceptionally well
24.09% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +10.9% this year.
Tap to view numbers
The price looks about right
Trading at 28.2 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +25.6% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.71% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 95.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FIW 0.05%
BEEZ 0.04%
GKAT 0.04%
CVRD 0.04%
KAT 0.04%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
VOO 1060.9B
IVV 844.4B
QQQ 481.7B
VUG 225.6B
IEFA 195.0BIt ranks #4 in the industry
Based on market cap of $40B.
A $40B PER 28.2
TMO $223B PER 32.5
DHR $141B PER 35.6
NTRA $47B PER -
실적분석 · 8/26 Agilent Technologies ($A) FY2026 Q3 Earnings Analysis — Revenue and Adjusted EPS Both Beat, Full-Year Guidance Raised 투자 가이드 · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is A?
A belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of A?
The market cap of A is approximately $40.3B, ranking 380 within its sector.
Does A pay dividends?
A has a dividend yield of approximately 0.71%, with an annual dividend of $1.02.
What is the P/E ratio of A?
A has a P/E ratio of approximately 28.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for A?
A has recorded a 52-week high of $163.75 and a low of $108.35.
